1. Shulman ST, Delnocencio J, Hirsch R. Kawasaki disease. Pediatr Clin North Am. 1995;42:1205-1222.
2.
2. Suzuki A, Kamiya T, Kuwahara N, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol. 1986;7:3-9.
3.
3. Furusho K, Kamiya T, Nakano H, et al. High dose intravenous gamma-globulin for Kawasaki disease. Lancet. 1984;2:1055-1058.
4.
4. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. NEnglf Med. 1986;315:341-347.
5.
5. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633-1639.
6.
6. Koren G, Lavi S, Rose V, et al. Kawasakidisease: review of risk factors for coronary aneurysms. J Pediatr. 1986;108:388-392.
7.
7. Daniels SR, Specker B, Capannari TE, et al. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease. Am JDis Child. 1987;141:205-207.
8.
8. Sundel RP, Burns JC,Baker A, et al. Gamma globulin retreatment in Kawasaki disease. J Pediatr1993;123:657-659.
9.
9. Burns JC, Capparelli EV, Brown JA, et al. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J1998;17:1144-1148.
10.
10. Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr. 1996;128:146-149.
